$4.$ CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL has just received an order from a large wholesaler in Germany for AUD$3,200,000$ of its products on April $26,2024,$ conditional upon delivery being made in three months time and the order

invoiced in euros. CSL management is concerned with the potential foreign exchange rate risk associated with this business, and asks you to conduct an analysis and make suggestions about hedging the exchange rate exposure.